Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

Christophe Mannaerts, Marc Engelbrecht, Arnoud Postema, Olivia Lodeizen, Rob van Kollenburg, Ruud van Sloun, Rogier Wildeboer, Massimo Mischi, Theo De Reijke, Hessel Wijkstra

Research output: Contribution to journalConference articleAcademicpeer-review

Abstract

Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

Fingerprint

Prostatic Neoplasms
Biopsy
Magnetic Resonance Imaging

Cite this

Mannaerts, Christophe ; Engelbrecht, Marc ; Postema, Arnoud ; Lodeizen, Olivia ; van Kollenburg, Rob ; van Sloun, Ruud ; Wildeboer, Rogier ; Mischi, Massimo ; De Reijke, Theo ; Wijkstra, Hessel. / Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?. In: Journal of Urology. 2019 ; Vol. 201, No. 4S. pp. e430-e430
@article{dc9e0e03b7a4451bbcb6918552e7ca87,
title = "Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?",
abstract = "Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.",
author = "Christophe Mannaerts and Marc Engelbrecht and Arnoud Postema and Olivia Lodeizen and {van Kollenburg}, Rob and {van Sloun}, Ruud and Rogier Wildeboer and Massimo Mischi and {De Reijke}, Theo and Hessel Wijkstra",
year = "2019",
month = "4",
day = "1",
doi = "10.1097/01.JU.0000557571.17930.bb",
language = "English",
volume = "201",
pages = "e430--e430",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier",
number = "4S",

}

Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy? / Mannaerts, Christophe; Engelbrecht, Marc; Postema, Arnoud; Lodeizen, Olivia; van Kollenburg, Rob; van Sloun, Ruud; Wildeboer, Rogier; Mischi, Massimo; De Reijke, Theo; Wijkstra, Hessel.

In: Journal of Urology, Vol. 201, No. 4S, 01.04.2019, p. e430-e430.

Research output: Contribution to journalConference articleAcademicpeer-review

TY - JOUR

T1 - Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

AU - Mannaerts,Christophe

AU - Engelbrecht,Marc

AU - Postema,Arnoud

AU - Lodeizen,Olivia

AU - van Kollenburg,Rob

AU - van Sloun,Ruud

AU - Wildeboer,Rogier

AU - Mischi,Massimo

AU - De Reijke,Theo

AU - Wijkstra,Hessel

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

AB - Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

U2 - 10.1097/01.JU.0000557571.17930.bb

DO - 10.1097/01.JU.0000557571.17930.bb

M3 - Conference article

VL - 201

SP - e430-e430

JO - Journal of Urology

T2 - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4S

ER -